Endo International plc – (NASDAQ:ENDP) (TSE:ENL) was the recipient of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 27,711,701 shares, a growth of 20.5% from the January 31st total of 22,990,959 shares. Based on an average daily trading volume, of 5,725,303 shares, the short-interest ratio is presently 4.8 days. Approximately 13.9% of the shares of the company are short sold.
Shares of Endo International (ENDP) opened at $6.31 on Thursday. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 10.78. The company has a market cap of $1,520.00, a P/E ratio of -1.14, a P/E/G ratio of 2.39 and a beta of 0.29. Endo International has a 1-year low of $5.77 and a 1-year high of $14.45.
Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.15. The company had revenue of $768.64 million for the quarter, compared to analysts’ expectations of $762.29 million. Endo International had a negative net margin of 126.97% and a positive return on equity of 66.98%. Endo International’s revenue was down 38.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.77 EPS. analysts expect that Endo International will post 3.67 earnings per share for the current fiscal year.
A number of hedge funds have recently modified their holdings of ENDP. Crossmark Global Holdings Inc. bought a new stake in Endo International during the 3rd quarter valued at $293,000. Gamco Investors INC. ET AL raised its holdings in Endo International by 76.2% during the 3rd quarter. Gamco Investors INC. ET AL now owns 110,500 shares of the company’s stock valued at $946,000 after acquiring an additional 47,800 shares during the period. Alps Advisors Inc. raised its holdings in Endo International by 9.3% during the 3rd quarter. Alps Advisors Inc. now owns 250,511 shares of the company’s stock valued at $2,146,000 after acquiring an additional 21,373 shares during the period. Van ECK Associates Corp raised its holdings in Endo International by 67.1% during the 3rd quarter. Van ECK Associates Corp now owns 340,991 shares of the company’s stock valued at $2,921,000 after acquiring an additional 136,873 shares during the period. Finally, LMR Partners LLP bought a new stake in Endo International during the 3rd quarter valued at $148,000. 92.54% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This piece was reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3229493/endo-international-plc-endp-sees-large-growth-in-short-interest.html.
About Endo International
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.